Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04734288 · ClinicalTrials.gov registry record · NA
LIFEHOUSE: Description of the Tent Bucket -Immune Support
A NA study, sponsored by Metagenics.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT04734288: Completed NA study, sponsored by Metagenics.
NCT04734288 is a NA study that has completed, run by Metagenics. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04734288, a NA study, has completed, sponsored by Metagenics.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
This immune support program will be an extension to the existing LIFEHOUSE program. Essential employees in Gig Harbor, WA; Colonial Heights, VA; Lenexa, KS, and Santa Fe Springs, CA, will be offered complimentary supplementation with commercially available nutritional supplements supportive of immune health for several months. The outcome will be measured via blood parameters and questionnaire responses.
Primary Outcome
The primary objective is to demonstrate the benefit of specific nutritional supplements, Vit.D3 5000 and Immune Active, as measured by demonstrable improvements in health, specifically a marker of nutritional status (25-hydroxy Vitamin D3 (25-OH D3)) and a marker of immune balance (high sensitivity c-reactive protein (hs-CRP) in a real-world setting.
Interventions
- DIETARY_SUPPLEMENT Vit.D3 5000 IU, Immune Active
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2021-01-22 |
| Est. Completion | 2022-12-31 |
| Phase | NA |
What the finished NCT04734288 record still lists
NCT04734288 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Vit.D3 5000 IU, Immune Active is the first listed.
NCT04734288 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04734288 about?
NCT04734288 is a clinical study titled "LIFEHOUSE: Description of the Tent Bucket -Immune Support". This immune support program will be an extension to the existing LIFEHOUSE program. Essential employees in Gig Harbor, WA; Colonial Heights, VA; Lenexa, KS, and Santa Fe Springs, CA, will be offered complimentary supplementation with commercially available nutritional supplements supportive of immun...
What is the current status of trial NCT04734288?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2021-01-22. Estimated completion is 2022-12-31.
What interventions are being tested in trial NCT04734288?
The interventions under investigation include: Vit.D3 5000 IU, Immune Active (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04734288?
This trial is sponsored by Metagenics, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04734288's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI